Sutro Biopharma Inc buy Piper Sandler
Start price
16.06.25
/
50%
€0.72
Target price
16.06.26
€1.73
Performance (%)
-12.78%
End price
17.06.26
-
Summary
This prediction is currently being closed. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.78%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sutro Biopharma Inc | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Piper_Sandler for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $2.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
In the thread Trading Sutro Biopharma Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.48
11.10.24
11.10.24
€10.05
11.10.25
11.10.25
-80.22%
12.10.25
12.10.25
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€10.16
03.04.25
03.04.25
-88.81%
04.04.25
04.04.25
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.28
15.11.23
15.11.23
€11.04
15.11.24
15.11.24
18.42%
16.11.24
16.11.24